The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.
Condition: Diffuse Large B-cell Lymphoma Interventions: Drug: Mitoxantrone hydrochloride liposome injection; Drug: RiTUXimab Injection; Drug: Cyclophosphamid; Drug: Vincristine; Drug: Prednisolone Sponsors: The First Hospital of Jilin University; CSPC Ouyi Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials